1 | CHOP-daclizumab | - | - | - | - | [1] 26 26 💬
|
2 | Daclizumab | [1] Daclizumab Daclizumab (Daclizumab) | [1] Daclizumab
Daclizumab
(Daclizumab) 💬
| [1] IL2RA IL2RA 💬
| [11] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [8] 13 13, 56, 60, 65, 97, 107, 283, 284 💬
|
3 | Daclizumab high yield process | [1] Daclizumab Daclizumab (Daclizumab) | [1] Daclizumab
Daclizumab
(Daclizumab) 💬
| [1] IL2RA IL2RA 💬
| [11] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 💬
|
4 | Daclizumab HYP | [1] Daclizumab Daclizumab (Daclizumab) | [1] Daclizumab
Daclizumab
(Daclizumab) 💬
| [1] IL2RA IL2RA 💬
| [11] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 💬
|
5 | Daclizumab HYP (DAC HYP | [1] Daclizumab Daclizumab (Daclizumab) | [1] Daclizumab
Daclizumab
(Daclizumab) 💬
| [1] IL2RA IL2RA 💬
| [11] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 💬
|
6 | Daclizumab HYP (DAC HYP) | [1] Daclizumab Daclizumab (Daclizumab) | [1] Daclizumab
Daclizumab
(Daclizumab) 💬
| [1] IL2RA IL2RA 💬
| [11] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 💬
|
7 | Daclizumab with greek suufix | [1] Daclizumab Daclizumab (Daclizumab) | [1] Daclizumab
Daclizumab
(Daclizumab) 💬
| [1] IL2RA IL2RA 💬
| [11] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 💬
|